Weglage J, Ullrich K, Pietsch M, Fünders B, Zass R, Koch H G
Department of Paediatrics, University of Münster, Germany.
Acta Paediatr. 1996 Mar;85(3):320-3. doi: 10.1111/j.1651-2227.1996.tb14024.x.
Twenty-four untreated adolescent and adult patients with non-phenylketonuria (PKU) hyperphenylalaninaemia (HPA) (serum phenylalanine levels < 600 mumol l-1) and 24 healthy controls matched for age, sex and IQ were investigated for their neurological outcome, especially for fine motor abilities by the Motor Performance Task. No pathological findings could be revealed by clinical neurological examination. Patients with HPA and healthy controls did not significantly differ in their fine motor performances. These performances were not significantly influenced by serum phenylalanine concentrations. Our results indicate that untreated patients with non-PKU HPA are not at clinically significant risk for developing fine motor deficits and severe neurological impairment. From this point of view a dietary treatment is not necessary in patients with HPA, as recommended most recently.
对24名未经治疗的非苯丙酮尿症(PKU)高苯丙氨酸血症(HPA)(血清苯丙氨酸水平<600 μmol l-1)的青少年和成年患者以及24名年龄、性别和智商相匹配的健康对照者进行了神经学结局调查,特别是通过运动表现任务来评估精细运动能力。临床神经学检查未发现病理结果。HPA患者和健康对照者在精细运动表现上无显著差异。这些表现不受血清苯丙氨酸浓度的显著影响。我们的结果表明,未经治疗的非PKU HPA患者发生精细运动缺陷和严重神经损伤的临床风险并不显著。从这一角度来看,如最近所建议的,对HPA患者进行饮食治疗并无必要。